Budget Impact of Chosing Rebif® as the Interferon of Choice for the Treatment of Relapsing-Remitting Multiple Sclerosis In the Brazilin Public Healthcare System
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1640
https://www.valueinhealthjournal.com/article/S1098-3015(15)01697-6/fulltext
Title :
Budget Impact of Chosing Rebif® as the Interferon of Choice for the Treatment of Relapsing-Remitting Multiple Sclerosis In the Brazilin Public Healthcare System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01697-6&doi=10.1016/j.jval.2015.03.1640
First page :
A281
Section Title :
Neurological Disorders
Open access? :
No
Section Order :
1118